FDA/Healthcare Regulation Our People

Related Publications

May/June 2008 Computer and Software Devices: FDA Seeks Framework for Regulation, FDLI's Update

(pdf)

05/08/08 Update on FDA Regulatory/Legislative Issues Impacting Drugs, Biologicals and Medical Devices, presented at the American Health Lawyers Association Life Sciences Law Institute, Bethesda, MD

04/25/08 Regulatory Process—Navigating the FDA: Moving from Product Concept to Product Clearance/Approval, presented at Morgan Lewis and Pittsburgh Life Sciences' Spring Training Briefing Series, Pittsburgh

View all publications

Related News

06/13/08 Chambers USA 2008 Recognizes Morgan Lewis in 19 National Practice Areas

Morgan Lewis is pleased to announce that the 2008 edition of Chambers USA: America’s Leading Lawyers for Business features Morgan Lewis as a leading national firm in 19 practice areas.

04/21/08 Morgan Lewis Launches Second Edition of Emerging Life Sciences Companies Deskbook

Morgan Lewis is pleased to announce the launch of the second edition of the Emerging Life Sciences Companies Deskbook.

09/14/07 141 Morgan Lewis Lawyers Receive The Best Lawyers in America (2008)

141 Morgan Lewis lawyers have been recognized in The Best Lawyers in America 2008.

View all news

Fast Facts

^PLCCross-border Quarterly 2008 Life Sciences Legal Market Review

Industry Super League - Ranked 16th among law firms worldwide
Regulatory Super League - Ranked 6th among law firms worldwide

^PLCCross-border Life Sciences Handbook 2007/2008

U.S. - Recognized for commercial/ partnering, competition/ antitrust, corporate, government law enforcement/ investigations, regulatory, regulatory/ medical devices, and patent counseling
England - Recognized for regulatory
Japan - Recognized for corporate/commercial

Chambers USA 2008: Recommended in Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory

UK Legal 500 2007/2008: London: Pharmaceuticals and Biotechnology

Areas of Experience

Related Practices

Life Sciences

page 1 of 1

	M. Elizabeth Bierman Partner Phone: 202.739.5206 mebierman@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Michele L. Buenafe Associate Phone: 202.739.6326 mbuenafe@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Natalie Kingston Associate Phone: +44 (0)20 3201 5525 nkingston@morganlewis.com	London Business and Finance
	Stephen P. Mahinka Partner Phone: 202.739.5205 smahinka@morganlewis.com	Washington, D.C. Life Sciences
	Alexis R. Miller Associate Phone: 202.739.5390 alexis.miller@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Phoebe Mounts Partner Phone: 202.739.5898 pmounts@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Andrew Ruskin Partner Phone: 202.739.5960 aruskin@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Kathleen M. Sanzo Partner Phone: 202.739.5209 ksanzo@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Dr. Sharon A. Segal Director of Regulatory Science Phone: 202.739.5427 ssegal@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Paul T. Sheives Regulatory Scientist Phone: 202.739.6305 psheives@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Anne E. Sullivan Associate Phone: 202.739.5789 anne.sullivan@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Dr. Lucy A. Vereshchagina, Ph.D. Regulatory Scientist Phone: 202.739.5299 lvereshchagina@morganlewis.com	Washington, D.C. FDA / Healthcare Regulation
	Anthony Warnock-Smith Partner Phone: +44 (0)20 3201 5511 awarnock-smith@morganlewis.com	London Business and Finance